Drug Approval | June 28, 2024
Eugia SEZ’s injectable facility gets EIR from USFDA
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations
First and only BTK inhibitor to demonstrate favourable overall survival trend vs. standard-of-care chemoimmunotherapy in this setting
Merck has opened its newly expanded Life Science distribution center in Schnelldorf, Germany
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
Subscribe To Our Newsletter & Stay Updated
